| scholarly article | Q13442814 |
| P2093 | author name string | Vladimir L Filatov | |
| Alexander E Kogan | |||
| Alexey G Katrukha | |||
| Anastasia V Bereznikova | |||
| Ekaterina V Koshkina | |||
| Marina N Bloshchitsyna | |||
| Kadriya S Mukharyamova | |||
| P2860 | cites work | The performance of quantitative D-dimer assays in laboratory routine | Q81043629 |
| Plasma D-dimer levels show correlation with number of lymph node metastases in patients with esophageal cancer | Q82081090 | ||
| New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores | Q82313733 | ||
| A model for the harmonisation of test results of different quantitative D-dimer methods | Q82769290 | ||
| A multicentric prospective study in usual care: D-dimer and cardiovascular events in patients with atrial fibrillation | Q84943379 | ||
| Diagnosis of deep venous thrombosis and pulmonary embolism | Q26829586 | ||
| Fibrin degradation product (FnDP) assays: analysis of standardization issues and target antigens in plasma | Q28303518 | ||
| D-dimer antigen: current concepts and future prospects | Q34014660 | ||
| Strategies for the safe and effective exclusion and diagnosis of deep vein thrombosis by the sequential use of clinical score, D-dimer testing, and compression ultrasonography | Q34120125 | ||
| Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. | Q34436452 | ||
| High D-dimer levels are associated with poor prognosis in cancer patients | Q36133005 | ||
| The harmonization of quantitative test results of different D-dimer methods | Q36319182 | ||
| Basic and clinical aspects of fibrinolysis and thrombolysis | Q36787030 | ||
| Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure | Q37024821 | ||
| Isolation of fibrin(OGEN) degradation products from normal plasma by affinity chromatographic study | Q39599706 | ||
| The utility and cost-effectiveness of D-dimer measurements in the diagnosis of deep vein thrombosis. | Q41595574 | ||
| Elevated D-dimers are also a marker of underlying malignancy and increased mortality in the absence of venous thromboembolism | Q43459360 | ||
| Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. | Q47824695 | ||
| D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy | Q47833058 | ||
| High plasma D-dimer level is associated with decreased survival in patients with lung cancer: a meta-analysis | Q47967832 | ||
| Plasma D-dimer level as a mortality predictor in patients with advanced or recurrent colorectal cancer. | Q50508477 | ||
| A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism. | Q51870182 | ||
| Measurement of crosslinked fibrin derivatives--use in the diagnosis of venous thrombosis | Q69044046 | ||
| Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome | Q69216058 | ||
| Clotting activation and impairment of fibrinolysis in malignancy | Q69233275 | ||
| Measurement of plasma D-dimer for diagnosis of deep venous thrombosis | Q69481678 | ||
| γ-γ Cross-linking sites in human and bovine fibrin | Q70735278 | ||
| Pooled patient samples as reference material for D-Dimer | Q70943612 | ||
| Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain | Q72041827 | ||
| D-dimer plasma measurement in patients undergoing major hip surgery: use in the prediction and diagnosis of postoperative proximal vein thrombosis | Q72186668 | ||
| Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study | Q72369100 | ||
| A comparative evaluation of ELISAs for D-dimer and related fibrin(ogen) degradation products | Q72553150 | ||
| D-dimer in patients with clinically suspected pulmonary embolism | Q72637543 | ||
| A reference material for harmonisation of D-dimer assays. Fibrinogen Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis | Q73418297 | ||
| Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A | Q73727699 | ||
| The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group | Q73848345 | ||
| D-dimer levels and risk of recurrent venous thromboembolism | Q73864376 | ||
| Disseminated intravascular coagulation: clinical and laboratory aspects | Q77177862 | ||
| Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock | Q77754970 | ||
| P433 | issue | 5 | |
| P921 | main subject | fibrin degradation product | Q2162109 |
| P304 | page(s) | 542-550 | |
| P577 | publication date | 2015-12-11 | |
| P1433 | published in | Blood Coagulation and Fibrinolysis | Q15752432 |
| P1476 | title | Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products | |
| P478 | volume | 27 |
| Q33833598 | Clinical significance of plasma D-dimer in ovarian cancer: A meta-analysis |
| Q92085775 | Elevated plasma D-dimer levels are associated with short-term poor outcome in patients with acute ischemic stroke: a prospective, observational study |
| Q64243719 | Generation and characterization of D-dimer specific monoclonal antibodies for use in latex agglutination test |
| Q101574203 | SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells |
| Q57463636 | What makes D-dimer assays suspicious-heterophilic antibodies? |
Search more.